ATRN-119

· Aprea Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATRN-119, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Study Of ATRN-119 In Patients With Advanced Solid Tumors [Phase 1, Phase 2]